Retrospective analysis of urine culture results in our clinic: determination of pathogen types and antibiotic resistance in our region

Abstract

Aim: Untreated urinary tract infections and increasing resistance to antibiotics are important health problems in pregnant and non-pregnant women. The aim of this study is to determine "Escherichia coli" (E. coli) strains and other growing microorganisms isolated from urine samples sent from pregnant and non-pregnant patients in the Gynecology and Obstetrics outpatient clinic in Mardin State Hospital, and evaluate the antimicrobial susceptibility profile. Materials and Methods: The results of reproduction in midstream urine samples obtained from pregnant and non-pregnant women who were sent to Mardin State Hospital Microbiology Laboratory with the suspicion of urinary system infection from the Gynecology and Obstetrics Outpatient Clinic between January 1, 2018 and June 17, 2020 were retrospectively evaluated. Results: The mean age of pregnant patients was significantly lower than that of the non-pregnant group. While E. Coli and Klebsiella were prominent in the pregnant group, the incidence of E. Coli and Enterococcus sp. had increased in the non-pregnant group. Conclusion: Urinary tract infection remains an important public health problem. To prevent the adverse obstetric consequences of urinary tract infection during pregnancy, it is important to investigate local susceptibility of microorganisms, especially common factors such as E. coli, at certain periods.

Keywords

• Urinary Tract Infection
• Pregnancy
• Escherichia coli
• Antibiotic Sensitivity
• Bacteriuria

References

1. Winn W Jr, Allen S, Janda W, Koneman E, Procop G, Schreckenberger P, Woods G. Koneman’s color atlas and textbook of diagnostic microbiology, 6th edition. Lippincott Williams & Wilkins, Baltimore, MD. 2006.
2. Coskun USS, Coskun G. Determination of the prevalence and antibiotic susceptibilities of extended spectrum beta-lactamase positive Escherichia coli strains ısolated from urine of outpatient patients of a state hospital. Kocatepe Tıp Derg. 2015;16:25-30.
3. Mert D, Çeken S, Ertek M; İdrar yolu enfeksiyonlarında kültürden izole edilen bakteriler ve antibiyotik duyarlılıkları.Turk Hij. Den. Biyol Derg, 2020;77: 25-32.
4. Forbes BA, Sahm DF, Weissfeld AS, Bailey WR. Bailey & Scott’s Diagnostic Microbiology. 12th Edition, Elsevier Mosby, St. Louis. 2007
5. Atalay CR, Ertürk NK. Gebelikte üriner sistem enfeksiyonları; Turkiye Klinikleri J Urology-Special Topics 2018;11:92-5.
6. Committee on Obstetric Practice. Committee Opinion No. 717: sulfonamides, nitrofurantoin, and risk of birth defects. Obstet Gynecol. 2017;130:e150-e152.
7. Budak G, Budak S, Arı A, et all. Investigating the distribution of the bacteria that lead to urinary tract infections and antibiotic susceptibility of E. Coli. J Clin Anal Med. 2015;6:216-8.
8. Johansen TE, Naber KG. Urinary Tract Infections. Antibiotics (Basel). 2014;3:375-7.

9. Marcon J, Stief CG, Magistro G. [Urinary tract infections : What has been confirmed in therapy?] Der Internist. 2017 ;58:1242-9.
10. Kahlmeter G, Poulsen HO. Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: the ECO·SENS study revisited. Int J Antimicrob Agents. 2012;39:45-51.
11. Zhanel GG, Karlowsky JA, Harding GK, et al. A Canadian national surveillance study of urinary tract isolates from outpatients: comparison of the activities of trimethoprim-sulfamethoxazole, ampicillin, mecillinam, nitrofurantoin, and ciprofloxacin. The Canadian Urinary Isolate Study Group. Antimicrob Agents Chemother. 2000;44:1089-92.
12. Belete MA, Saravanan M. A systematic review on drug resistant urinary tract ınfection among pregnant women in developing countries in Africa and Asia; 2005-2016. Infect Drug Resist. 2020;13:1465-77.
13. Forson AO, Tsidi WB, Nana-Adjei D, Quarchie MN, Obeng-Nkrumah N. Correction to: Escherichia coli bacteriuria in pregnant women in Ghana: antibiotic resistance patterns and virulence factors. BMC Res Notes. 2019;12:29.
14. Dautt-Leyva JG, Canizalez-Román A, Acosta Alfaro LF, Gonzalez-Ibarra F, Murillo-Llanes J. Maternal and perinatal complications in pregnant women with urinary tract infection caused by Escherichia coli. J Obstet Gynaecol Res. 2018;44:1384-90.
15. Shaeer KM, Zmarlicka MT, Chahine EB, Piccicacco N, Cho JC. Plazomicin: a next-generation aminoglycoside. Pharmacotherapy. 2019;39:77-93.
16. Eljaaly K, Alharbi A, Alshehri S, Ortwine JK, Pogue JM. Plazomicin: a novel aminoglycoside for the treatment of resistant gram-negative bacterial ınfections. Drugs. 2019;79:243-69.